Emerging HIV treatment options were at the forefront of CROI 2021. Here are my key takeaways from some of the most intriguing presentations.
Highly anticipated data on long-acting PrEP options in development were presented at CROI 2021. Here are my interpretations of these data and considerations for future implementation.
Hear insights from Chloe Orkin, MBChB, FRCP, MD, on exciting new HIV data reported at the virtual CROI 2021, including new findings on HIV PrEP, HIV and COVID-19, ART in pregnancy and the postpartum period, as well as on the comparative efficacy of various ARV regimens.
In this downloadable slideset, CCO’s expert faculty members summarize key studies from this important annual conference, including new data on the following hot topics: HIV PrEP strategies; ART in pregnancy, the postpartum period, children and adolescents; racial disparities in COVID-19 outcomes among PWH; HIV and coinfections/comorbidities; and current and investigational ART.